Daniel F. Hayes, MD, FASCO, Elected ASCO President for 2016-2017 Term
Daniel F. Hayes, MD, FASCO, has been elected President of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2016. He will take office as President-Elect during the ASCO Annual Meeting in Chicago in June 2015.
“I'm honored to be elected incoming President of ASCO, which has had such a major influence on my professional career,” said Dr. Hayes. “I look forward to working with ASCO leadership and staff on the critical initiatives within the oncology community including new strategies for health-care reform; the development of CancerLinQTM; efforts to improve value in cancer care; personalized cancer care; and reducing global disparities in cancer treatment. ASCO is uniquely positioned to tackle these issues head-on, and I look forward to being part of this exciting time in the life of the Society.”
Dr. Hayes, a breast cancer specialist, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. An ASCO member since 1986, Dr. Hayes served on the ASCO Board of Directors from 2011 to 2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board.
He has served on several Expert Panels related to breast cancer, including the ASCO-College of American Pathologists Estrogen Receptor/Progesterone Receptor and the HER2 Testing Panels (Co-Chair), the Breast Cancer Consensus Panel, Use of Tumor Biomarkers in Advanced Breast Cancer and Early-Stage Breast Cancer Panels, and the Breast Cancer Guideline Advisory Group, among others. In 2007, he was presented with ASCO's Gianni Bonadonna Breast Cancer Award and Lecture.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
